A.N. Galustyan

ORCID: 0000-0001-9679-632X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pediatric health and respiratory diseases
  • Respiratory and Cough-Related Research
  • Respiratory viral infections research
  • Asthma and respiratory diseases
  • Pharmaceutical studies and practices
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Infections and Vaccines
  • Metabolism and Genetic Disorders
  • Influenza Virus Research Studies
  • Mitochondrial Function and Pathology
  • Medicinal plant effects and applications
  • Human Health and Disease
  • Sleep and related disorders
  • Neonatal Respiratory Health Research
  • Healthcare Systems and Public Health
  • Pneumonia and Respiratory Infections
  • COVID-19 Clinical Research Studies
  • Streptococcal Infections and Treatments
  • Ginseng Biological Effects and Applications
  • Sympathectomy and Hyperhidrosis Treatments
  • Phytoestrogen effects and research
  • Pharmacological Effects of Natural Compounds
  • Herbal Medicine Research Studies
  • Osteoarthritis Treatment and Mechanisms
  • Gastroesophageal reflux and treatments

Saint Petersburg State Pediatric Medical University
2011-2024

Medical Technologies (Czechia)
2023

Ministry of Health of the Russian Federation
2016-2021

BIOCAD (Russia)
2017

Ming‐Chih Lin Leonardo R. Brandão Matteo Luciani Lisa Bomgaars Elizabeth Chalmers and 88 more Lesley Mitchell Ildar Nurmeev Anjali Sharathkumar Pavel Svirin Kirill Gorbatikov Igor Tartakovsky Monika Simetzberger Fenglei Huang Zhichao Sun Jörg Kreuzer Savion Gropper Paul A. Reilly Martina Brueckmann Manuela Albisetti Ildar Nurmeev А. И. Сафина Ondřej Zapletal Leonardo R. Brandão Tomáš Kuhn Tomáš Votava Judy Felgenhauer Anjali Sharathkumar Pavel Svirin Ali Amid Ming‐Chih Lin Kirill Gorbatikov Paola Saracco Csongor Kiss Susan Halimeh Madlen Reschke Beate Wulff Michèle David Zbyněk Novák I.I. Trunina Manuela Albisetti Tony Frisk Heidi Glosli Andreas H. Groll O. Lvova İlgen Şaşmaz Darintr Sosothikul Virginija Žilinskaitė Erin Cockrell V. A. Digtyar I Hadacová Sauli Palmu Anjali Pawar Joyce Maria Annichino Bizzacchi Ümran Çalışkan Tıraje Celkan Dmytro Dmytrіiev Colleen Druzgal Graciela Elena Antonis Kattamis Ramazan Kavakli Christoph Male Nihal Özdemir An Van Damme T. N. Zvereva Aanen Aarli Rogelio Alejandro Paredes Aguilera Selin Aytaç Jorge David Aivazoglou Carneiro Antonio Chistolini M.G. Mazzucconi Fernando F. Corrales‐Medina Françis Couturaud Stacey E Croteau Cameron C. Trenor Michael Damgaard Natalia Dixon A.N. Galustyan Jiří Hák Marianne Hoffmann Alphan Küpesiz Veerle Labarque Chris Van Geet Ming‐Chih Lin Yun‐Ching Fu Sandra Regina Loggetto Veerle Mondelaers Irena Odri-Komazec Shoshana Revel‐Vilk Julián Sevilla Luciano Fuzzato Silva José Kerr Saraiva Fernando Montes‐Tapia Wendy Woods‐Swafford

10.1016/s2352-3026(20)30368-9 article EN The Lancet Haematology 2020-12-05

BACKGROUND: Safe and effective oral treatments are needed to improve clinical outcomes for nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small-molecule ribonucleoside prodrug shown inhibit replication of severe acute respiratory syndrome coronavirus 2 in vitro animal models. METHODS: MOVe-OUT ongoing, phase 2/3, randomized, placebo-controlled, double-blind study evaluating the safety, efficacy, pharmacokinetics molnupiravir adults. In component, participants...

10.1056/evidoa2100043 article EN NEJM Evidence 2021-12-21

Aim . A meta-analysis of 8 controlled studies (n=771, age 53.6±6.2 years) tie use Chondroguard (100 mg i.m. first 3 injections, from 4th injection - 200 i.m., EOD, course 20-30 injections) in the complex therapy osteoarthritis (OA). Materials and Methods Tie according to fixed-effects model included all published clinical on efficacy safety CG drug OA). The effectiveness was assessed using VAS, Lequesne, WOMAC scales/indices. For each study, information collected 23 features. Data analysis...

10.17749/2070-4909/farmakoekonomika.2020.066 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2021-02-07

Introduction. The English-language databases PubMed/MEDLINE and Embase are valuable information resources for finding original publications in basic clinical medicine. Currently, there no artificial intelligence systems to evaluate the quality of these publications. Aim. Development testing a system sentiment analysis (i.e. emotional modality) biomedical Materials methods. technique "Big data" was formulated on basis topological theory analysis. Algorithms have been developed that allow...

10.17749/2070-4909/farmakoekonomika.2020.021 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2020-08-09

Objective : a comparative analysis of 6 different chondroprotectors for injection, containing chondroitin sulfate (CS) based on natural extracts. Material and methods . Five samples were studied each CS extract. The preparations compared the basis profiles trace element composition, sulfur content, chromatographic test total protein. In sample, concentration 72 elements was determined, then averaging performed variances content calculated. To assess protein fraction, modified Lowry method...

10.17749/2070-4909/farmakoekonomika.2021.083 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2021-04-29

Objective: the development and verification of a scale for identifying patients at high risk osteoarthritis (OA). Material methods. The results analysis sample aged 35–90 years from database Institute Trace Elements ( n =3440), which included information on clinical anamnestic, diagnostic parameters pharmacotherapy patients, including with OA =107), are presented. To analyze about modern methods data proposed within topological theory pattern recognition were used. Results. Based sample,...

10.17749/2070-4909/farmakoekonomika.2023.158 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2023-02-20

The review considers pharmacological characteristics of new antiepileptic drugs (AEDs) the third generation such as eslicarbazepine, lacosamide, retigabine, perampanel, everolimus, brivaracetam, zonisamide. data on mechanisms action, pharmacokinetics, drug interactions, indications for use and side effects are presented. recognized superior in safety efficacy to previously known AEDs first second generations. majority is used control focal seizures, well specific epileptic syndromes...

10.17749/2077-8333/epi.par.con.2023.149 article EN cc-by-nc-sa Epilepsy and Paroxysmal Conditions 2023-07-09

Aim : to conduct a comparative clinical and economic analysis of using three SYSADOA drugs containing chondroitin sulfate or modifying its biosynthesis in patients with stage II knee osteoarthritis an outpatient setting. Material methods . This was retrospective study, the inclusion data from medical records outpatients arthritis according Kellgren & Lawrence classification. We calculated cost-effectiveness direct costs treatment efficiency based on dynamics pain, functional ability joint...

10.17749/2070-4909.2019.12.4.255-266 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2020-02-18

научный биометрический журнал, который знакомит читателя с клиническими рекомендациями и особенностями применения лекарственных вакцинных средств у детей, предоставляет исчерпывающую информацию о воздействии на плод, проводимых в

10.15690/pf.v11i5.1161 article RU cc-by-nc Педиатрическая фармакология 2014-01-01

<h3>Background</h3> BCD-085 is an innovative humanized monoclonal antibody against interleukin-17 with genetically modified Fc- and CDR-regions, aimed to improve treatment outcomes in patients several autoimmune disorders. <h3>Objectives</h3> To study pharmacokinetics safety of a single SC injection ascending doses healthy male volunteers. <h3>Methods</h3> A standard "3+3" first-in-human dose escalation phase 1 clinical design was used. Different cohorts volunteers 18 45 years age received...

10.1136/annrheumdis-2016-eular.1615 article EN Annals of the Rheumatic Diseases 2016-06-01

As vaccine-induced immunity and protection following natural pertussis infection wane over time, adults adolescents may develop become transmitters to unprotected infants. In Russia, diphtheria tetanus but not pertussis-containing vaccines are registered for older children, adolescents, or adults. The reduced-antigen-content toxoid, acellular (dTpa) vaccine (Boostrix, GSK) was developed booster vaccination of children ≥4 years age, A phase III, open-label, non-randomized study performed in...

10.1080/21645515.2020.1796423 article EN cc-by Human Vaccines & Immunotherapeutics 2020-08-26

In 2010, the Russian Federation (RF) registered palivizumab — innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children disease severe progress risk group, which include primarily premature infants, with bronchopulmonary dysplasia and hemodynamically significant congenital heart disease. Currently, is included list recommended medicines medical care standards different countries, including Russia. review...

10.15690/vramn.v69i7-8.1110 article EN Annals of the Russian academy of medical sciences 2014-01-01

We assessed the immunogenicity and safety of combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in children Russian Federation aiming to support registration Russia. In this phase 3, non-randomized, open-label study (NCT02858440), healthy received three primary doses at 4.5, 6 months age (N = 235) a booster dose 18 225). Seroprotection rates against diphtheria, tetanus, Hib, poliovirus 1–3, seropositivity pertussis...

10.1080/21645515.2020.1720437 article EN cc-by Human Vaccines & Immunotherapeutics 2020-02-12

The article presents the results of a clinical investigation on administration Grippol Quadrivalent vaccine (influenza tetravalent inactivated subunit adjuvant vaccine) in children from 6 months to 5 years old. has demonstrated no less effectiveness comparison with plus trivalent polymer-subunit vaccine).comparable were obtained for all evaluated indicators immunological efficacy against matching strains influenza virus, while additional strain B (Yamagata line) there was statistically...

10.15690/pf.v21i3.2743 article EN cc-by-nc Педиатрическая фармакология 2024-04-27

Objective: to determine the molecular mechanisms of action 7-hydroxymatairesinol (7(OH)MR), main lignan spruce extracts, characterized by oncoprotective and anti-inflammatory properties. Material methods. The analysis 7(OH)MR was carried out chemoinformatic approach using combinatorial theory solvability topological recognition. postgenomic makes it possible assess effect drugs on genome transcription (transcriptome) proteome as a whole. Results. 7(OH)MP has (inhibition 5-lipoxygenase,...

10.17749/2070-4909/farmakoekonomika.2024.240 article EN cc-by-nc-sa FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology 2024-05-15

Insomnia is a widespread problem in the pediatric population. The prevalence of insomnia childhood varies from 5% to 50%. lack adequate therapy can lead chronicity, impairment cognitive and motor functions, eventually development cardiovascular metabolic diseases, diabetes, gastrointestinal mental disorders. Thus, timely identification treatment important. This study aimed summarize systematize current information about modern approach pharmacotherapy chronic childhood. Modern foreign...

10.17816/rcf624874 article EN Reviews on Clinical Pharmacology and Drug Therapy 2024-06-04

Vitamin sufficiency in children can be estimated by the different values of their consumption autumn-winter and spring-summer seasons. The paper presents results a study assessing prevalence vitamin deficiency among various ages depending on season. included adolescents aged from 3 to 14 years (n = 2587, 51% boys) regions Russia. As result, significant seasonal differences were found 3–14 years. Analysis clusters parameter interactions demonstrated relationship between vitamins B6, E, A, B2...

10.21518/2079-701x-2016-07-20-27 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2016-01-01

Results of the prospective study conducted to assess perinatal risk factors contribution in asthma phenotypes formation childhood are presented. Of 712 children, which have been observed from first wheezing onset St Petersburg’s state ambulances, 238 children with bronchial developed later years life were included random sample. Bronchial proceeded structure atopic disease 128 (phenotype ABA), and as part limited allergic lesion respiratory tract - 110 RBA). It was found that mother,...

10.17816/ped7247-56 article EN cc-by Pediatrician (St Petersburg) 2016-06-15
Coming Soon ...